Nomura Holdings Inc ADR NMR
10.06
0.29
2.97%
as of 25 Sep
- Market cap
- $28.6B
- P/E
- 10.3×
Follow NMR
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Jun '25 | Sep '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
8.89 | 8.87 | — | 8.96 |
P/S ratio |
0.61 | 0.67 | — | 0.78 | |
P/FCF ratio |
0.00 | 4.00 | — | 4.79 | |
P/Operating CF |
(7.91) | 3.33 | — | 3.99 | |
P/B ratio |
0.79 | 0.87 | — | 1.02 | |
Price to Tangible BV |
0.80 | 0.88 | — | 1.03 | |
EV/Sales |
1.45 | 1.34 | — | (3.38) | |
EV/EBITDA |
1.94 | 1.79 | — | 0.00 | |
EV/Operating CF |
(29.62) | 7.31 | — | (18.88) | |
EV/FCF |
(21.15) | 8.04 | — | (20.76) | |
Quick Ratio |
0.91 | 0.91 | 0.89 | 1.75 | |
Current Ratio |
1.13 | 1.13 | 1.12 | 2.00 | |
Net Debt/EBITDA |
4.52 | 3.77 | 0.00 | (22.31) | |
Debt/Assets |
46.83% | 46.10% | 46.45% | 47.17% | |
Debt/Equity |
7.58 | 7.71 | 7.54 | 8.06 | |
Asset Turnover |
0.08 | 0.16 | 0.00 | 0.08 | |
Operating CF/Net income |
0.00 | 10.24 | — | 0.00 | |
Capex/Depreciation |
— | 0.09 | — | — | |
Interest Coverage |
0.00 | 0.00 | — | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
22.43% | 23.39% | — | 23.78% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | 0.00% | |
Graham Net Nets |
(8.35) | (7.68) | — | (0.04) | |
Graham Number |
11.78 | 12.41 | — | 13.79 | |
Earnings Yield |
11.25% | 11.28% | — | 11.16% | |
Free Cash Flow Yield |
(11.15%) | 25.01% | — | 20.86% | |
Revenue per Share |
2.69 | 2.69 | — | 2.96 | |
Operating CF per Share |
0.00 | 2.18 | — | 0.00 | |
Capex per Share |
0.00 | 0.01 | — | 0.00 | |
Free Cash Flow per Share |
0.00 | 2.19 | — | 0.00 | |
Cash per Share |
54.24 | 57.07 | 0.00 | 116.30 | |
Shareholders Equity per Share |
8.33 | 8.35 | 0.00 | 8.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.33 | 8.35 | 0.00 | 8.63 | |
Free Cash Flow |
— | 6,430.43 | — | — | |
Working Capital |
24,445.10 | 25,213.20 | 22,835.80 | 201,692.60 | |
Capital Expenditures |
— | 19.28 | — | — | |
Net Current Asset Value |
(163,307.30) | (164,045.30) | (164,180.50) | (1,060.10) | |
EV/EBIT |
1.93 | 1.81 | — | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
Net Profit Margin |
9.04% | 7.93% | — | 10.61% | |
Price to Operating Income |
4.12 | 4.24 | — | 4.37 | |
| Other line items | |||||
Average Receivables |
9,448.31 | 9,906.05 | 9,371.48 | 11,688.03 | |
Average Payables |
28,223.03 | 30,009.61 | 30,995.17 | 32,506.05 | |
Average Assets |
390,706.60 | 205,250.20 | 393,775.70 | 414,654.15 | |
Average Common Equity |
24,279.25 | 23,671.67 | 23,775.32 | 24,708.05 |
Columns are period end dates